NextCell invited presenter at International Society for Cell and Gene Therapy meeting in Paris
NextCell Pharma AB´s ("NextCell" or the"Company") CSO, Dr Lindsay Davies, has been invited to give a poster presentation at the ISCT meeting in Paris, showcasing NextCell´s long-term follow-up data from their phase II type I diabetes study with investigative medicinal product, ProTrans.Dr Davies has been invited to present a poster at the ISCT meeting, entitled, “A single infusion of ProTrans mesenchymal stromal cell product maintains endogenous insulin production in type 1 diabetes patients – a long term follow-up study.” This year´s ISCT meeting will focus on “celebrating the progress
